Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.
Thomas
J M
JM
Depártment of Surgery, East Carolina University School of Medicine, Greenville, North Carolina 27858.
Carver
F M
FM
Cunningham
P R
PR
Gross
U
U
Verbanac
K M
KM
Rebellato
L M
LM
Riley
R
R
Thomas
F T
FT
D000818:Animals; D000917:Antibody Formation; D000920:Antibody-Dependent Cell Cytotoxicity; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000096:biosynthesis*; D016030:Kidney Transplantation / Q000276:immunology*; D008253:Macaca mulatta; D008297:Male; D011817:Rabbits
D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007518:Isoantibodies